메뉴 건너뛰기




Volumn 56, Issue 7-8, 2010, Pages 311-318

Prevalence of CYP450 gene variations in patients with type 2 diabetes

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; EDETIC ACID; GENOMIC DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

EID: 77957368486     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (22)
  • 1
    • 4344684441 scopus 로고    scopus 로고
    • Pharmacogenetics and drug development: The path to safer and more effective drugs
    • DOI 10.1038/nrg1432
    • Roses AD. Pharmacogenetics and Drug Development: The Path to safer and more effective Drugs. Nature Rev 2004;5:645-56. (Pubitemid 39150121)
    • (2004) Nature Reviews Genetics , vol.5 , Issue.9 , pp. 645-656
    • Roses, A.D.1
  • 4
  • 7
    • 0034792584 scopus 로고    scopus 로고
    • Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
    • DOI 10.1046/j.0306-5251.2001.01499.x
    • Goldstein JA. Clinical relevance of genetic polymorphisms in human CYP2C subfamily. Br J Clin Pharmacol 2001; 52:349-55. (Pubitemid 32939439)
    • (2001) British Journal of Clinical Pharmacology , vol.52 , Issue.4 , pp. 349-355
    • Goldstein, J.A.1
  • 8
    • 0037328994 scopus 로고    scopus 로고
    • Pharmacogenetics of the major polymorphic metabolizing enzymes
    • DOI 10.1046/j.1472-8206.2003.00119.x
    • Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 2003;17:27-41. (Pubitemid 36241451)
    • (2003) Fundamental and Clinical Pharmacology , vol.17 , Issue.1 , pp. 27-41
    • Daly, A.K.1
  • 9
    • 0030841936 scopus 로고    scopus 로고
    • Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism
    • DOI 10.1016/S0300-9084(97)81496-4
    • Latruffe N, Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie 1997;79:81-94. (Pubitemid 27290347)
    • (1997) Biochimie , vol.79 , Issue.2-3 , pp. 81-94
    • Latruffe, N.1    Vamecq, J.2
  • 10
    • 33644918580 scopus 로고    scopus 로고
    • Pioglitazone: An antidiabetic drug with the potency to reduce cardiovascular mortality
    • DOI 10.1517/14656566.7.4.463
    • Pfützner A, Forst T. Pioglitazone, an anti-diabetic drug with the potency to reduce cardiovascular mortality. Expert Opin Pharmacother. 2006;7:463-76. (Pubitemid 43379612)
    • (2006) Expert Opinion on Pharmacotherapy , vol.7 , Issue.4 , pp. 463-476
    • Pfutzner, A.1    Forst, T.2
  • 11
    • 0002103003 scopus 로고    scopus 로고
    • PPARgamma agonists in type 2 diabetes: How far have we come in 'preventing the inevitable'? - A review of the metabolic effects of rosiglitazone
    • Zinman B. PPAR gamma agonists in type 2 diabetes: how far have we come in 'preventing the inevitable'? A review of the metabolic effects of rosiglitazone. Diabetes Obes Metab. 2001;3(Suppl 1):S34-43. (Pubitemid 33720704)
    • (2001) Diabetes, Obesity and Metabolism , vol.3 , Issue.SUPPL. 1
    • Zinman, B.1
  • 13
    • 0036720991 scopus 로고    scopus 로고
    • Rapid and reliable method for cytochrome P450 2D6 genotyping
    • Stamer UM, Bayerer B, Wolf S, Hoeft A, Stüber F. et al. (2002) Rapid and Reliable Method for Cytochrome P450 2D6 Genotyping. Clin Chem. 2002 Sep;48(9):1412-7. (Pubitemid 34925775)
    • (2002) Clinical Chemistry , vol.48 , Issue.9 , pp. 1412-1417
    • Stamer, U.M.1    Bayerer, B.2    Wolf, S.3    Hoeft, A.4    Stuber, F.5
  • 14
    • 17444453992 scopus 로고    scopus 로고
    • Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR
    • DOI 10.1373/49.10.1624
    • Müller B, Zöpf K, Bachofer J, Steimer W. et al. (2003) Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR. Clin Chem. 2003 Oct;49 (10):1624-31. (Pubitemid 37194216)
    • (2003) Clinical Chemistry , vol.49 , Issue.10 , pp. 1624-1631
    • Muller, B.1    Zopf, K.2    Bachofer, J.3    Steimer, W.4
  • 16
    • 48849098300 scopus 로고    scopus 로고
    • Functional role of Ile264 in CYP2C8: Mutations affect haem incorporation and catalytic activity
    • Singh R, Ting JG, Pan Y, Teh LK, Ismail R, Ong CE. Functional role of Ile264 in CYP2C8: mutations affect haem incorporation and catalytic activity. Drug Metab Pharmacokinet. 2008;23:165-174.
    • (2008) Drug Metab Pharmacokinet. , vol.23 , pp. 165-174
    • Singh, R.1    Ting, J.G.2    Pan, Y.3    Teh, L.K.4    Ismail, R.5    Ong, C.E.6
  • 21


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.